While pregnant women are included in those thought to be at high risk for COVID-19, not much is actually known yet about the virus' potential impacts on pregnancy.
But a University of Washington obstetrician and professor hopes to change that, shifting her lab's research into the new virus.
As lockdowns sweep the country and people prepare to work from home for months, many are wondering whether springtime’s warmer temperatures will provide much-needed relief from the coronavirus. Others, including President Donald Trump, have made the case that it’s a certainty.
When we asked you to submit questions for three Seattle-area leaders about the COVID-19 pandemic, you responded in droves.
In less than 24 hours, Seattle Times readers submitted more than 400 questions for our video interview Thursday with our three panelists:
Seattle’s Infectious Disease Research Institute has received seven-figure funding to begin human trials on a potentially groundbreaking novel coronavirus treatment.
The study could launch within weeks, take about 11 months to complete, and enroll about 100 patients diagnosed with a COVID-19 infection that’s causing moderate to severe pneumonia. It would deploy cancer-fighting NK-cells as an immunotherapy treatment for the coronavirus rather than the current approach of antiviral medication.
Patricia García, Peru's former Minister of Health and an Affiliate Professor of Global Health at the University of Washington, spoke to Publimetro in her home country of Peru about the country's response to the coronavirus pandemic. García received a Masters of Public Health at UW and is also a professor at the School of Public Health at Cayetano Heredia University in Lima, Peru. Her areas of expertise include epidemiology, infectious diseases, and implementation science.
The following interview has been translated from Spanish.
As the coronavirus spreads, Seattle and its suburbs have become America’s laboratory and guinea pig.
The response now touches every part of daily life. From restaurant closures to bans on gatherings to the total reorientation in the area's research centers, sweeping changes arrive at a pace unimaginable two weeks ago.
Two weeks ago, Dr. Peter Rabinowitz, director of the UW MetaCenter for Pandemic Disease Preparedness, rated his concern level for coronavirus at seven or eight out of ten. On Friday, Rabinowitz said he’s now rating his concern at an eight or nine.
By John Lynch (MPH '11) and Karin Huster (MPH '13)
As we swiftly surpass 100,000 cases and 4,000 deaths globally, every one of us is understandably rattled and may be asking, will I be next? Will I get infected with COVID-19? Will I end up in the hospital? Will it kill me, my family or friends?
Watch the webcast of the Conference on Retroviruses and Opportunistic Infections (CROI) Special Session on COVID-19, held March 10, 2020.
In parts of Africa, where the rate of HIV is high, researchers found that using mobile vans to dispense antiretroviral treatment and other care greatly increased viral suppression.
Researchers enrolled 1,315 people living with HIV and not on antiretroviral treatment in a nearly three-year study in South Africa and Uganda using mobile vans to dispense treatment.